Key result
Serum chitotriosidase activity rises stepwise with CAD extent, reaching ~2.2-fold higher levels in 3-vessel disease.
Why the study?
Atherosclerosis is an inflammatory process involving macrophage differentiation into foam cells, and because chitotriosidase is quantitatively secreted by activated macrophages, this study investigated the association between serum chitotriosidase activity and atherosclerotic CAD.
Is serum chitotriosidase activity associated with the presence and angiographic extent of coronary artery disease in patients with suspected stable ischemic heart disease?
Cross-Sectional (n=200)
Single-blind (operators reading the angiograms were unaware of the results of any laboratory analyses)
No
Is serum chitotriosidase activity associated with the presence and angiographic extent of coronary artery disease in patients with suspected stable ischemic heart disease?
Answers are grounded in this paper and cite their sources.
Serum chitotriosidase activity is significantly elevated in patients with stable coronary artery disease and increases stepwise with the number of diseased coronary vessels, suggesting utility as a quantitative inflammatory biomarker of atherosclerotic burden.
BACKGROUND: Atherosclerosis is considered to be an inflammatory disease in which the initial process is augmented infiltration of monocytes into the vessel wall and their subsequent differentiation from macrophages into lipid-laden foam cells. Chitotriosidase is one of the most quantitative proteins secreted by activated macrophages, so the aim of this study was to investigate the association of the level of serum chitotriosidase activity with atherosclerotic coronary artery disease (CAD). METHODS AND RESULTS: A total of 200 subjects undergoing coronary angiography were divided into 4 subgroups according to the number of diseased vessels and their serum chitotriosidase activity levels were measured. Serum chitotriosidase activity in patients with CAD was significantly higher than in normal control subjects (p<0.001). Serum chitotriosidase activity was also significantly associated with the extent of CAD as defined by the number of stenosed vessels (p<0.001). CONCLUSION: Serum chitotriosidase activity can be considered a strong inflammatory marker of CAD. Moreover, plasma chitotriosidase activity may be also regarded as a quantitative indicator of disease extent, as well as being a marker of disease presence.
No takes yet. Share an insight, caveat, or question.
Karadağ et al. (2007) conducted a cross-sectional in Suspected stable coronary artery disease undergoing coronary angiography (n=200). Presence and angiographic extent of coronary artery disease (1-vessel, 2-vessel, or 3-vessel disease with >=50% luminal stenosis) vs. Control subjects with strictly normal coronary angiograms (n=53) was evaluated on Serum chitotriosidase activity (mmol·ml⁻¹·h⁻¹) (p=<0.001). Serum chitotriosidase activity increased stepwise with coronary artery disease extent from 83±10.3 in controls to 111±10.8, 138±12.02, and 179±11.4 mmol·ml⁻¹·h⁻¹ in 1-, 2-, and 3-vessel disease.
Synapse has enriched 10 related papers. Consider them for comparative context: